Pharmacokinetics_PK_in_Action
Example - Sparse sampling NCA
Using Pharmacometrics to Optimize Sparse Sampling Study Designs in Paediatric and Special Population Studies.
Population pharmacokinetics | PPT
Identifying an optimal dihydroartemisinin-piperaquine dosing regimen for malaria prevention in young Ugandan children | Nature Communications
Pharmaceutics | Free Full-Text | Machine Learning and Pharmacometrics for Prediction of Pharmacokinetic Data: Differences, Similarities and Challenges Illustrated with Rifampicin
Frontiers | Impact of Inaccurate Documentation of Sampling and Infusion Time in Model-Informed Precision Dosing
Visualization of Sparse PK Concentration Sampling Data, Step by Step (Improvement by Improvement)
Visualization of Sparse PK Concentration Sampling Data, Step by Step (Improvement by Improvement)
Visualization of Sparse PK Concentration Sampling Data, Step by Step (Improvement by Improvement)
Population-based PK in haemophilia A - ppt download
PFIM D-optimal sampling times and IBR sampling windows superimposed on... | Download Scientific Diagram
New Model–Based Bioequivalence Statistical Approaches for Pharmacokinetic Studies with Sparse Sampling | The AAPS Journal
Random sparse sampling strategy using stochastic simulation and estimation for a population pharmacokinetic study - ScienceDirect
Applied Sciences | Free Full-Text | On the Interplay between Machine Learning, Population Pharmacokinetics, and Bioequivalence to Introduce Average Slope as a New Measure for Absorption Rate
Visualization of Sparse PK Concentration Sampling Data, Step by Step (Improvement by Improvement)
Listing code of NONMEM analyses of the sparse data | Download Scientific Diagram
Clinical Pharmacokinetic Studies | UM College of Pharmacy
Population pharmacokinetic model development and its relationship with adverse events of oxcarbazepine in adult patients with epilepsy | Scientific Reports
